Hiroshi Egusa

Prof. Hiroshi Egusa

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Prosthodontic Research
Verified
Journal Article
Open access
MYMasahiro Yamada
Masahiro Yamada
HEHiroshi Egusa
Hiroshi Egusa
Alveolar ridge augmentation is essential for success in implant therapy and depends on the biological performance of bone graft materials. This literature review aims to comprehensively explain the clinically relevant capabilities and limitations of currently available bone substitutes for bone augmentation in light of biomaterial science. The biological performance of calcium phosphate-based bone substitutes was categorized according to space-making capability, biocompatibility, bioabsorption, and volume maintenance over time. Each category was reviewed based on clinical studies, preclinical animal studies, and in vitro studies. Currently available bone substitutes provide only osteoconduction as a scaffold but not osteoinduction. Particle size, sensitivity to enzymatic or chemical dissolution, and mechanical properties affect the space-making capability of bone substitutes. The nature of collagen fibers, particulate size, and release of calcium ions influence the biocompatibility of bone substitutes. Bioabsorption of bone substitutes is determined by water solubility (chemical composition) and acid resistance (integrity of apatite structure). Bioabsorption of remnant bone substitute material and volume maintenance of the augmented bone are inversely related. It is necessary to improve the biocompatibility of currently available bone substitutes and to strike an appropriate balance between bioabsorption and volume maintenance to achieve ideal bone remodeling.

1 January 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
NKNadia Kartikasari
Nadia Kartikasari
MYMasahiro Yamada
Masahiro Yamada
JWJun Watanabe
Jun Watanabe
WTWatcharaphol Tiskratok
Watcharaphol Tiskratok
XHXindie He
Xindie He
HEHiroshi Egusa
Hiroshi Egusa

7 October 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JMJeeranan Manokawinchoke
Jeeranan Manokawinchoke
PPPrasit Pavasant
Prasit Pavasant
CSChenphop Sawangmake
Chenphop Sawangmake
NLNuttapol Limjeerajarus
Nuttapol Limjeerajarus
CLChalida N. Limjeerajarus
Chalida N. Limjeerajarus
TOThanaphum Osathanon
Thanaphum Osathanon
Mechanical force regulates periodontal ligament cell (PDL) behavior. However, different force types lead to distinct PDL responses. Here, we report that pretreatment with an intermittent compressive force (ICF), but not a continuous compressive force (CCF), promoted human PDL (hPDL) osteogenic differentiation as determined by osteogenic marker gene expression and mineral deposition in vitro. ICF-induced osterix (OSX) expression was inhibited by cycloheximide and monensin. Although CCF and ICF significantly increased extracellular adenosine triphosphate (ATP) levels, pretreatment with exogenous ATP did not affect hPDL osteogenic differentiation. Gene-expression profiling of hPDLs subjected to CCF or ICF revealed that extracellular matrix (ECM)-receptor interaction, focal adhesion, and transforming growth factor beta (TGF-β) signaling pathway genes were commonly upregulated, while calcium signaling pathway genes were downregulated in both CCF- and ICF-treated hPDLs. The TGFB1 mRNA level was significantly increased, while those of TGFB2 and TGFB3 were decreased by ICF treatment. In contrast, CCF did not modify TGFB1 expression. Inhibiting TGF-β receptor type I or adding a TGF-β1 neutralizing antibody attenuated the ICF-induced OSX expression. Exogenous TGF-β1 pretreatment promoted hPDL osteogenic marker gene expression and mineral deposition. Additionally, pretreatment with ICF in the presence of TGF-β receptor type I inhibitor attenuated the ICF-induced mineralization. In conclusion, this study reveals the effects of ICF on osteogenic differentiation in hPDLs and implicates TGF-β signaling as one of its regulatory mechanisms.

12 June 2017 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
SMShoko Miura
Shoko Miura
SKShin Kasahara
Shin Kasahara
SYShinobu Yamauchi
Shinobu Yamauchi
YOYayoi Okuyama
Yayoi Okuyama
AIAkio Izumida
Akio Izumida
HEHiroshi Egusa
Hiroshi Egusa

13 March 2014 in Stem Cells and Development
Verified
Journal Article
Closed access
HEHiroshi Egusa
Hiroshi Egusa
HKHiroki Kayashima
Hiroki Kayashima
JMJiro Miura
Jiro Miura
SUShinya Uraguchi
Shinya Uraguchi
FWFangfang Wang
Fangfang Wang
HYHirofumi Yatani
Hirofumi Yatani
Induced pluripotent stem cells (iPSCs) can differentiate into mineralizing cells and are, therefore, expected to be useful for bone regenerative medicine; however, the characteristics of iPSC-derived osteogenic cells remain unclear. Here, we provide a direct in vitro comparison of the osteogenic differentiation process in mesenchymal stem cells (MSCs) and iPSCs from adult C57BL/6J mice. After 30 days of culture in osteogenic medium, both MSCs and iPSCs produced robustly mineralized bone nodules that contained abundant calcium phosphate with hydroxyapatite crystal formation. Mineral deposition was significantly higher in iPSC cultures than in MSC cultures. Scanning electron microscopy revealed budding matrix vesicles in early osteogenic iPSCs; subsequently, the vesicles propagated to exhibit robust mineralization without rich fibrous structures. Early osteogenic MSCs showed deposition of many matrix vesicles in abundant collagen fibrils that became solid mineralized structures. Both cell types demonstrated increased expression of osteogenic marker genes, such as runx2 , osterix, dlx5 , bone sialoprotein (BSP), and osteocalcin, during osteogenesis; however, real-time reverse transcription–polymerase chain reaction array analysis revealed that osteogenesis-related genes encoding mineralization-associated molecules, bone morphogenetic proteins, and extracellular matrix collagens were differentially expressed between iPSCs and MSCs. These data suggest that iPSCs are capable of differentiation into mature osteoblasts whose associated hydroxyapatite has a crystal structure similar to that of MSC-associated hydroxyapatite; however, the transcriptional differences between iPSCs and MSCs could result in differences in the mineral and matrix environments of the bone nodules. Determining the biological mechanisms underlying cell-specific differences in mineralization during in vitro iPSC osteogenesis may facilitate the development of clinically effective engineered bone.

1 November 2020 in Biomaterials
Verified
Journal Article
Closed access
MZMaolin Zhang
Maolin Zhang
JSJunfeng Shi
Junfeng Shi
MXMing Xie
Ming Xie
JWJin Wen
Jin Wen
KNKunimichi Niibe
Kunimichi Niibe
XJXinquan Jiang
Xinquan Jiang